about
The human platelet alloantigen profile in blood donors from Amazonas, Brazil.A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia.Reversible cerebral vasoconstriction syndrome following red blood cells transfusion: a case series of 7 patients.Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.Frequency and pattern of noninfectious adverse transfusion reactions at a tertiary care hospital in KoreaNeurological Complications following Blood Transfusions in Sickle Cell Anemia.Nurses' knowledge of blood transfusion in neonate.Efficiency and safety of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A systematic review and meta-analysis.Transfusion-related adverse reactions in pediatric and surgical patients at a tertiary care teaching hospital in India.Peptide Mimetic Drugs for Modulating Thrombosis and Hemostasis.Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.The Non-Hemostatic Aspects of Transfused Platelets.Robotic hysterectomy in Trendelenburg position in a severely anaemic JKa alloimmunised patient with impending high-output cardiac failure: An anaesthetic challenge.Thromboelastometry-guided hemostatic therapy for hemorrhagic shock in the postoperative period of vascular surgery: a case report.Reversible splenial lesion syndrome after blood transfusion presents callosal disconnection syndrome: A case report.The efficacy and safety of anti-fibrinolytic agents in blood management following peri-acetabular osteotomy: A meta-analysisBlood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity
P2860
Q33434661-3804DEC4-1928-4871-9D63-7B34BF13CFACQ33442065-47318E93-3CF7-474A-B7CB-8F764DEB62BCQ35564418-2AAD1065-A510-44E6-92C5-79017DA8C14DQ35922810-5A516CA8-9F45-44CE-9AEB-C5FF6FF85B5EQ36419679-338EB17D-9F7E-49E3-AA1D-5E01DF285AABQ37588706-E43C353D-C872-4D6E-8C7F-B21D639B4AD1Q38704474-2AF5D2C4-592B-448A-BD14-9FF8F0331812Q39341090-2E971373-CFFB-4BFB-B09D-63FCEDD21C54Q41825858-C3DC9F5F-96E8-4482-BC36-5F95E4832A7DQ44874794-7172D284-A0ED-4C3C-955E-654D27656414Q47579942-4FDFFE9D-55DC-495D-81EF-89C8FEA4788DQ54941751-B22B31A9-97FE-4F0C-B57F-6CC868BCF169Q55250389-60F6E7E0-6040-4F5D-B935-1786DFCFE10BQ55427325-FDB639F4-7F64-4CB7-80ED-15331123AD3BQ55497278-B5691CCC-37BB-4983-B120-AB33D4FA6291Q58706760-ABBCF0E8-E560-4AD7-8943-55275A4C4965Q58739338-C71DBF51-EFE8-4D9A-B7C7-FB56CDA00F62
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Adverse events related to blood transfusion
@ast
Adverse events related to blood transfusion
@en
Adverse events related to blood transfusion
@nl
type
label
Adverse events related to blood transfusion
@ast
Adverse events related to blood transfusion
@en
Adverse events related to blood transfusion
@nl
prefLabel
Adverse events related to blood transfusion
@ast
Adverse events related to blood transfusion
@en
Adverse events related to blood transfusion
@nl
P2093
P2860
P356
P1476
Adverse events related to blood transfusion
@en
P2093
Anupam Verma
Sandeep Sahu
P2860
P304
P356
10.4103/0019-5049.144650
P407
P577
2014-09-01T00:00:00Z